Home/Filings/4/0001171843-16-007723
4//SEC Filing

Anika Therapeutics, Inc. 4

Accession 0001171843-16-007723

$ANIKCIK 0000898437operating

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 4:07 PM ET

Size

6.9 KB

Accession

0001171843-16-007723

Insider Transaction Report

Form 4
Period: 2016-02-04
SHERWOOD CHARLES H
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2016-02-04+22,600264,055 total
  • Award

    Stock Option (Right to Buy)

    2016-02-04+63,50063,500 total
    Exercise: $38.11Exp: 2026-02-04Common Stock (63,500 underlying)
Footnotes (2)
  • [F1]Restricted stock awards vest in four equal annual installments beginning February 4, 2017.
  • [F2]The stock options vest in four equal annual installments beginning February 4, 2017.

Documents

1 file

Issuer

Anika Therapeutics, Inc.

CIK 0000898437

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000898437

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:07 PM ET
Size
6.9 KB